Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Jan 2024 for Acutus Medical, Inc., €1,095.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Kevin Mathews: trading record in brief
All filings by Kevin Mathews on record concern Acutus Medical, Inc. Over a trading history stretching from 5 August 2022 to 7 January 2024, the count stands at 6 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 18 January 2024, the filings show a share grant worth €1,095 in Acutus Medical, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kevin Mathews
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
6,342 shares@ US$0.18968.2% of flowForm 4SEC:0001628280-24-001669:0
134 shares@ US$0.695.3% of flowFORM 4SEC:0001628280-23-027854:0
321 shares@ US$0.75413.8% of flowFORM 4SEC:0001628280-23-010612:0
42,500 shares0FORM 4SEC:0001628280-23-006082:0
3,540 shares@ €1.721879.2% of flowFORM 4SEC:0001628280-23-002077:0
134 shares@ US$1.5612.7% of flowCommon StockSEC:0000950103-22-013824:0
6 of 6 declarations
